Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

7.580 -0.340 (-4.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 225,354
Open 7.950
Bid (Size) 7.500 (30)
Ask (Size) 8.140 (1)
Prev. Close 7.920
Today's Range 7.530 - 8.000
52wk Range 1.520 - 11.46
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Preview: Lifecore Biomedical's Earnings
Via Benzinga

Performance

YTD
+19.37%
+19.37%
1 Month
-9.55%
-9.55%
3 Month
-17.79%
-17.79%
6 Month
+124.93%
+124.93%
1 Year
-17.70%
-17.70%

More News

Read More
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Recap: Lifecore Biomedical Q3 Earnings
Via Benzinga
Preview: Lifecore Biomedical's Earnings
Via Benzinga
Analyst Ratings for Lifecore Biomedical
Via Benzinga
Why Lifecore Biomedical Shares Are Skyrocketing Today
Via Benzinga
Top 5 Risk Off Stocks That May Plunge In Q2
Via Benzinga
Lifecore Biomedical Q3 Misses Street Estimates, Explores 'Strategic Alternatives'
Via Benzinga
Earnings Scheduled For June 1, 2023
Via Benzinga
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Analyst Ratings for Lifecore Biomedical
Via Benzinga
Lifecore Biomedical, Inc. - Common Stock's Return On Capital Employed Insights
Via Benzinga
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dow Drops Over 100 Points; Lowe's Earnings Top Views
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Top 4 Defensive Stocks That You May Want To Dump This Month
Via Benzinga
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023
Via Benzinga
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.